Unexpected Side Effects of a High S-1 Dose: Subanalysis of a Phase III Trial Comparing Gemcitabine, S-1 and Combinatorial Treatments for Advanced Pancreatic Cancer

Publisher： Karger

E-ISSN： 1423-0232|91|3|117-126

ISSN： 0030-2414

Source： Oncology, Vol.91, Iss.3, 2016-06, pp. : 117-126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase I Study of Combination Chemotherapy with Gemcitabine and Oral S-1 for Advanced Pancreatic Cancer

By  

Oncology, Vol. 69, Iss. 5, 2005-12 ,pp. : 421-427

Karger

Access to resources Recommend Favorite

Randomized clinical trial of adjuvant chemotherapy with S‐1 versus gemcitabine after pancreatic cancer resection

By  

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 7, 2015-06 ,pp. : 746-754

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Pilot Study for Combination Chemotherapy Using Gemcitabine and S-1 for Advanced Pancreatic Cancer

By  

Oncology, Vol. 77, Iss. 5, 2009-11 ,pp. : 300-303

Karger

Access to resources Recommend Favorite

Biweekly gemcitabine plus S‐1 for locally advanced and metastatic pancreatic cancer: a preliminary feasibility study

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 9, 2015-09 ,pp. : 692-698

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I Trial of Gemcitabine Dose Escalation with Concurrent Radiotherapy for Patients with Locally Advanced Pancreatic Cancer

By  

Pancreatology, Vol. 10, Iss. 1, 2010-03 ,pp. : 60-65

Karger

Access to resources Recommend Favorite